Compounds > etodolac

etodolac and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

etodolac has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, M; Hakozaki, M; Hojo, H; Kikuchi, S1

Other Studies

1 other study(ies) available for etodolac and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

ArticleYear
Etodolac, a selective cyclooxygenase-2 inhibitor, induces apoptosis by activating caspases in human malignant rhabdoid tumor cells (FRTK-1).
    Oncology reports, 2007, Volume: 17, Issue:1

    Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Caspases; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors; Cysteine Proteinase Inhibitors; Enzyme Activation; Etodolac; Humans; Isoenzymes; Rhabdoid Tumor

2007